Int J Biol Sci 2021; 17(5):1315-1327. doi:10.7150/ijbs.58102 This issue Cite

Research Paper

PAK5-mediated AIF phosphorylation inhibits its nuclear translocation and promotes breast cancer tumorigenesis

Yao Xing1#, Yang Li1#, Bingtao Hu1, Fuyi Han1, Xin Zhao1, Hongyan Zhang1, Yanshu Li1, Danni Li3, Jiabin Li1, Feng Jin2✉, Feng Li1✉

1. Department of Cell Biology, Key Laboratory of Cell Biology of National Health Commission of the PRC, Key Laboratory of Medical Cell Biology of Ministry of Education of the PRC, China Medical University, No.77, Puhe Road, Shenyang, 110122, Liaoning, China.
2. Department of Breast Surgery, Department of Surgical Oncology, Research Unit of General Surgery, The First Affiliated Hospital of China Medical University, No. 155, North Nanjing Street, Heping District, 110001 Shenyang, Liaoning, China.
3. Department of Medical Oncology, The First Affiliated Hospital of China Medical University, Shenyang, China.
#These authors contributed equally to this work.

Citation:
Xing Y, Li Y, Hu B, Han F, Zhao X, Zhang H, Li Y, Li D, Li J, Jin F, Li F. PAK5-mediated AIF phosphorylation inhibits its nuclear translocation and promotes breast cancer tumorigenesis. Int J Biol Sci 2021; 17(5):1315-1327. doi:10.7150/ijbs.58102. https://www.ijbs.com/v17p1315.htm
Other styles

File import instruction

Abstract

Graphic abstract

Although p21 activated kinase 5 (PAK5) is related to the progression of multiple cancers, its biological function in breast cancer remains unclear. Apoptosis-inducing factor (AIF) is a vital apoptosis factor in mitochondria, which can be released from mitochondria and enter the nucleus, causing caspase-independent apoptosis. In this study, we reveal that PAK5 inhibits apoptosis by preventing the nuclear translocation of AIF. PAK5 inhibits the release of AIF from mitochondria in breast cancer cells by decreasing the mitochondria membrane permeability and increasing the membrane potential. Furthermore, PAK5 phosphorylates AIF at Thr281 site to inhibit the formation of AIF/importin α3 complex, leading to decrease AIF nuclear translocation. Functionally, we demonstrate that PAK5-mediated AIF phosphorylation promotes the proliferation of breast cancer cells and accelerates the growth of breast cancer in vivo. Significantly, PAK5 and AIF expression in breast cancer are positively correlated with poor patient prognosis. PAK5 expression is negatively correlated with AIF nuclear translocation. These results suggest that PAK5-AIF signaling pathway may play an essential role in mammary tumorigenesis, providing a new therapeutic target for the treatment of breast cancer.

Keywords: PAK5, AIF, breast cancer, apoptosis


Citation styles

APA
Xing, Y., Li, Y., Hu, B., Han, F., Zhao, X., Zhang, H., Li, Y., Li, D., Li, J., Jin, F., Li, F. (2021). PAK5-mediated AIF phosphorylation inhibits its nuclear translocation and promotes breast cancer tumorigenesis. International Journal of Biological Sciences, 17(5), 1315-1327. https://doi.org/10.7150/ijbs.58102.

ACS
Xing, Y.; Li, Y.; Hu, B.; Han, F.; Zhao, X.; Zhang, H.; Li, Y.; Li, D.; Li, J.; Jin, F.; Li, F. PAK5-mediated AIF phosphorylation inhibits its nuclear translocation and promotes breast cancer tumorigenesis. Int. J. Biol. Sci. 2021, 17 (5), 1315-1327. DOI: 10.7150/ijbs.58102.

NLM
Xing Y, Li Y, Hu B, Han F, Zhao X, Zhang H, Li Y, Li D, Li J, Jin F, Li F. PAK5-mediated AIF phosphorylation inhibits its nuclear translocation and promotes breast cancer tumorigenesis. Int J Biol Sci 2021; 17(5):1315-1327. doi:10.7150/ijbs.58102. https://www.ijbs.com/v17p1315.htm

CSE
Xing Y, Li Y, Hu B, Han F, Zhao X, Zhang H, Li Y, Li D, Li J, Jin F, Li F. 2021. PAK5-mediated AIF phosphorylation inhibits its nuclear translocation and promotes breast cancer tumorigenesis. Int J Biol Sci. 17(5):1315-1327.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image